Markets › United States › NYSE › GRDN

Guardian Pharmacy Services Inc

NYSE:GRDNHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$40.14+1.70%At closeAt close · Tue 20 Oct · ≈ AED 147.41 · Market cap $2.54B · Next earnings Mon 9 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	20.0%	20.4%	20.4%	19.9%	19.9%	19.5%	—	—
Operating margin	4.4%	3.8%	5.7%	3.9%	−5.1%	6.1%	6.1%	+0.0 pts
Net margin	2.7%	2.1%	3.9%	2.3%	−7.1%	3.4%	3.4%	+0.0 pts
EBITDA margin	6.7%	5.9%	7.5%	5.6%	−3.5%	6.7%	—	—
Return on equity	51.8%	68.2%	82.9%	84.7%	−61.2%	23.9%	22.6%	−1.3 pts
Return on assets	9.2%	6.9%	13.8%	8.8%	−27.2%	11.9%	11.9%	+0.0 pts
Return on capital employed	24.4%	24.3%	36.1%	30.8%	−35.6%	35.3%	—	—
Debt / equity	1.5×	2.3×	1.5×	2.5×	0.3×	0.2×	0.2×	−5.6%
Debt / assets	27.0%	23.3%	24.6%	25.5%	11.6%	9.0%	—	—
Interest coverage	14.9×	18.4×	27.0×	14.3×	−19.2×	133.7×	—	—
Current ratio	1.1×	1.0×	1.1×	0.9×	1.1×	1.4×	1.4×	+0.0%
Quick ratio	0.7×	0.7×	0.7×	0.7×	0.8×	1.1×	—	—
Cash ratio	0.1×	0.1×	0.0×	0.0×	0.0×	0.4×	0.4×	+0.0%
Asset turnover	3.4×	3.4×	3.5×	3.9×	3.8×	3.5×	—	—
Inventory turnover	18.4×	19.1×	17.4×	22.8×	24.3×	26.9×	—	—
Receivables turnover	16.1×	14.3×	13.4×	13.5×	12.6×	14.3×	—	—
Dividend payout	54.2%	106.4%	87.0%	160.7%	−41.0%	0.0%	—	—